help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on June 15, 2007, doi:10.1165/rcmb.2006-0364OC

Am. J. Respir. Cell Mol. Biol., Volume 37, Number 4, October 2007, 494-500

A more recent version of this article appeared on October 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0364OCv1
37/4/494    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, D.
Right arrow Articles by Chung, K. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, D.
Right arrow Articles by Chung, K. F.

Submitted on September 26, 2006
Revised on June 11, 2007

Inhibition of Airway Smooth Muscle Adhesion and Migration by the Disintegrin Domain of ADAM-15

Dong Lu1, ShaoPing Xie2, Maria B Sukkar2, Xinjie Lu1, Michael F Scully3*, and Kian Fan Chung2

1 Molecular Immunology Section, Thrombosis Research Institute, London, United Kingdom, 2 Experimental Studies Unit, Airways Disease Section, National Heart and Lung Institute, London, United Kingdom, 3 Proteomics Section, Thrombosis Research Institute, London, United Kingdom

* To whom correspondence should be addressed. E-mail: mscully{at}tri-london.ac.uk.

Disintegrin and metalloprotease proteins (ADAMs) are membrane-anchored glycoproteins involved in cell adhesion, cell fusion, protein ecto-domain shedding and intracellular signaling. We examined whether the disintegrin domain of ADAM-15 (named ddADAM-15) containing an Asp-Gly-Asp (RGD) integrin-binding motif could interfere with airway smooth muscle cell (ASMC) adhesion and migration. Recombinant ddADAM-15 adhered to human ASMCs with saturation kinetics, and was {beta}1-integrin-dependent. ddADAM-15 inhibited the binding of fibrinogen but not of fibronectin to ASMCs. ddADAM-15 also inhibited PDGF-induced ASMC migration, and this was reversed by an anti-{beta}1 integrin antibody. PDGF induced the activation of phosphoinositol-3-kinase (PI3K) and p38 mitogen-activated protein kinase (MAPK), and selective inhibitors of these kinases inhibited PDGF-induced ASMC migration. ddADAM-15 did not inhibit PDGF-induced activation of PI3K or p38, thereby excluding these kinase pathways as a mechanism by which ddADAM-15 inhibits ASMC migration. ADAM-15 mRNA and protein were expressed under basal conditions, and both gene and protein expression were inhibited by PDGF. Inhibition of endogenous ADAM-15 with a blocking antibody directed at the disintegrin domain of ADAM-15 did not alter PDGF-induced ASMC migration, possibly because of the inhibitory effect of PDGF on endogenous ADAM-15 expression. In summary, ddADAM-15 inhibits ASMC adhesion and migration through the {beta}1-integrin, without modulating signaling pathways involved in ASMC migratory responses.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2007 American Thoracic Society.
  2009/2010 ATS Fellows Career Development Awards